A pivotal trial of Tryton Medical's side-branch stent fails to meet its non-inferiority endpoint for target vessel failure, although most of the patients in the study fell outside its target parameters.
A pivotal clinical trial of Tryton Medical's side-branch stent, the largest ever conducted on coronary bifurcation lesions, failed to meet its primary endpoint for target vessel failure.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1vTXiiE
Cap comentari:
Publica un comentari a l'entrada